Stockscreener 앱 받기
33.00
0.12%
0.04
시간 외 거래:
33.01
0.010
+0.03%
전일 마감가:
$32.96
열려 있는:
$33.39
하루 거래량:
681.73K
Relative Volume:
0.81
시가총액:
$1.23B
수익:
$272.30M
순이익/손실:
$-5.14M
주가수익비율:
-201.83
EPS:
-0.1635
순현금흐름:
$42.76M
1주 성능:
+5.74%
1개월 성능:
-15.69%
6개월 성능:
-15.19%
1년 성능:
+28.21%
1일 변동 폭
$32.19
$33.39
1주일 범위
$30.02
$33.39
52주 변동 폭
$25.21
$54.85
Harrow Inc Stock (HROW) Company Profile
명칭
Harrow Inc
전화
615.733.4731
주소
1A BURTON HILLS BLVD, NASHVILLE, CA
Compare HROW vs TAK, HLN, TEVA, ZTS, UTHR
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
HROW
Harrow Inc
|
33.00 | 1.23B | 272.30M | -5.14M | 42.76M | -0.1635 |
TAK
Takeda Pharmaceutical Co Adr
|
16.25 | 52.07B | 29.91B | 1.30B | 3.49B | 0.4056 |
HLN
Haleon Plc Adr
|
9.29 | 41.28B | 14.54B | 2.22B | 2.58B | 0.4871 |
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
34.07 | 39.78B | 17.53B | 1.58B | 444.18M | 1.3457 |
ZTS
Zoetis Inc
|
81.32 | 33.57B | 9.51B | 2.64B | 2.14B | 6.0361 |
UTHR
United Therapeutics Corp
|
568.43 | 24.02B | 3.17B | 1.29B | 1.01B | 27.09 |
Harrow Inc Stock (HROW) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-07-11 | 개시 | Cantor Fitzgerald | Overweight |
| 2025-06-12 | 개시 | BTIG Research | Buy |
| 2025-06-10 | 개시 | William Blair | Outperform |
| 2025-02-06 | 개시 | H.C. Wainwright | Buy |
| 2024-12-04 | 재확인 | B. Riley Securities | Buy |
| 2024-04-11 | 개시 | Craig Hallum | Buy |
| 2022-09-08 | 재개 | B. Riley Securities | Buy |
| 2021-10-14 | 재개 | B. Riley Securities | Buy |
| 2021-09-24 | 개시 | Aegis Capital | Buy |
| 2021-07-02 | 개시 | Ladenburg Thalmann | Buy |
모두보기
Harrow Inc 주식(HROW)의 최신 뉴스
Harrow (HROW) Is Up 6.8% After Reaffirming 2026 Revenue Outlook Despite Wider Q1 LossesWhat's Changed - simplywall.st
Harrow Inc (HROW) Shares Surge 6.8% -- What GF Score of 82 Tells Investors - GuruFocus
Why B.Riley Reduced Harrow, Inc. (HROW) Price Target Despite Long-Term Optimism - Insider Monkey
Harrow: Demand Keeps It Interesting, Valuation Keeps It A Hold - Seeking Alpha
Harrow, Inc. 2026 Q1ResultsEarnings Call Presentation (NASDAQ:HROW) 2026-05-19 - Seeking Alpha
Harrow director Lauren Silvernail buys $31,000 in company stock By Investing.com - Investing.com Nigeria
Harrow director Adrienne Graves buys $31,070 in company stock By Investing.com - Investing.com Nigeria
Harrow director Lauren Silvernail buys $31,000 in company stock - Investing.com India
Insider Buying: Adrienne Graves Acquires Shares of Harrow Inc (H - GuruFocus
5 Best Small Cap Pharma Stocks to Buy Right Now - Insider Monkey
Harrow (HROW) director Adrienne Graves buys 1,000 shares at $31.07 - Stock Titan
Harrow (HROW) director purchases 1,000 common shares at $31.00 price - Stock Titan
Harrow projects $71M-$81M Q2 revenue while reaffirming $350M-$365M 2026 outlook - MSN
[Form 4] HARROW, INC. Insider Trading Activity - Stock Titan
Mark Baum Buys Handful Of Shares In Harrow - Yahoo Finance
Harrow’s TRIESENCE Phase 3 Milestone Adds New Dimension To Growth Story - Sahm
Harrow Stock (HROW) Opinions on Q1 Earnings and Insider Buying - Quiver Quantitative
Harrow (HROW) Executives Make Notable Stock Purchases - GuruFocus
Why Harrow (HROW) Narrative Is Shifting As Analysts Recut Targets Yet Stay Positive - Yahoo Finance
Insider Buying: Mark Baum Acquires Additional Shares of Harrow I - GuruFocus
Harrow Insider Bought Shares Worth $302,000, According to a Recent SEC Filing - Moomoo
Harrow, Inc. CEO Mark L. Baum buys $302,000 in common stock - Investing.com India
Harrow president and CFO Andrew Boll buys $104,650 in stock By Investing.com - Investing.com Australia
Harrow president and CFO Andrew Boll buys $104,650 in stock - Investing.com India
Harrow, Inc. CEO Mark L. Baum buys $302,000 in common stock By Investing.com - Investing.com South Africa
Harrow (HROW) CEO Mark Baum acquires 10,000 shares in open-market buy - Stock Titan
Harrow (NASDAQ: HROW) CFO adds 3,500 shares in open-market buy - Stock Titan
Harrow Inc (HROW) Shares Surge 3.5% -- What GF Score of 82 Tells Investors - GuruFocus
B. Riley Securities Maintains Harrow(HROW.US) With Buy Rating, Cuts Target Price to $60 - Moomoo
B. Riley Adjusts Price Target on Harrow to $60 From $65, Maintains Buy Rating - Moomoo
The Harrow, Inc. (NASDAQ:HROW) First-Quarter Results Are Out And Analysts Have Published New Forecasts - Yahoo Finance
Why Harrow (HROW) Is Down 25.9% After Q1 Miss And Reaffirmed 2026 Guidance – And What's Next - simplywall.st
HROW Maintained by Cantor Fitzgerald -- Price Target Lowered to $88 - GuruFocus
Transcript: Harrow Q1 2026 Earnings Conference Call - Sahm
Cantor Fitzgerald Maintains Harrow(HROW.US) With Buy Rating, Cuts Target Price to $88 - Moomoo
HROW Alert: Monsey Law Firm of Wohl & Fruchter LLP Investigating Harrow for Potential Securities Law Violations - marketscreener.com
Lake Street Maintains Harrow(HROW.US) With Buy Rating, Maintains Target Price $60 - Moomoo
Harrow Health, Inc. (NASDAQ:HROW) Q1 2026 Earnings Call Transcript - Insider Monkey
BTIG Maintains Harrow(HROW.US) With Buy Rating, Maintains Target Price $63 - Moomoo
Harrow stock seeks recovery after plummet - Nashville Post
Harrow Inc (HROW) Q1 2026 Earnings Call Highlights: Strong Product Demand Amid Revenue Challenges - Investing.com Canada
Harrow Stock Tumbles on Weaker 1Q Revenue, Wider Loss - Moomoo
Harrow (HROW) Q1 Loss Of US$27.6 Million Rekindles Profitability Concerns - simplywall.st
Harrow, Inc. (HROW) Reports Q1 2026 Earnings with Positive Outlo - GuruFocus
Harrow Inc (HROW) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.92%
4.44%
자본화:
|
볼륨(24시간):